Clinical Meetings - Formulary

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Clinical Meetings

Statins found beneficial in wider range of patients, major study finds

January 1, 2002

Anaheim, CA-The largest trial of cholesterol-lowering therapy ever conducted extends the current indications for statin therapy, reported Rory Collins, MD.

For first time, an antianginal agent shown to improve clinical outcomes

January 1, 2002

An agent developed specifically for the treatment of angina reduces the incidence of major coronary events, reported Henry Dargie, MD, who presented the results of a trial known as the Impact of Nicorandil in Angina (IONA). It is believed to be the first large-scale trial to report on the effects of a specific antianginal drug on clinical outcome.

Ranolazine enhances exercise performance when added to standard medications

January 1, 2002

Ranolazine, the first in a new class of antianginal agents called the partial fatty acid oxidation (pFOX) inhibitors, improves exercise performance and reduces angina frequency in patients who still have symptoms despite treatment with other antianginal medications, according to Bernard Chaitman, MD. He reported the results of a Phase III study called the Combination Assessment of Ranolazine in Stable Angina (CARISA).

Dutasteride reduces prostate cancer incidence in men at high risk

June 15, 2009

Dutasteride reduces the risk of biopsy-detectable prostate cancer by approximately one-fourth in men at high risk for the disease without increasing the risk of high-grade cancers, said Gerald L. Andriole, Jr, MD, at the American Urological Association (AUA) 2009 Annual Meeting.

Immunotherapy improves survival in advanced prostate cancer

June 15, 2009

Sipuleucel-T represents the "first active immunotherapy to demonstrate improvement in overall survival for advanced prostate cancer," said David Penson, MD, MPH, who announced the results of a phase 3 study known as Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT), at the American Urological Association (AUA) 2009 Annual Meeting.

Rivaroxaban superior to enoxaparin in preventing VTE after knee arthroplasty

May 15, 2009

Results from the Regulation of Coagulation in Orthopaedic Surgery to Prevent Deep Vein Thrombosis and Pulmonary Embolism 4 (RECORD4) trial published in Lancet demonstrated that rivaroxaban 10 mg once daily is superior to subcutaneous (SC) enoxaparin in preventing venous thromboembolism (VTE) after total knee arthroplasty.

Clinical judgment is best guide in determining appropriate medications for elderly patients

May 15, 2009

Good clinical pharmacy judgment is still the most useful tool in evaluating the prescription needs of seniors, according to speakers at the American College of Clinical Pharmacy (ACCP)/European Society for Clinical Pharmacy (ESCP) International Congress on Clinical Pharmacy meeting in Orlando, Florida, but the pharmacy professionals still reviewed various criteria and methods that can assist in evaluating senior patients, particularly those with cardiovascular disease.

Serious ADRs associated with psychotropic use in children

May 15, 2009

Prescribing psychotropic medications for attention-deficit/hyperactivity disorder (ADHD) and other disorders in children is common around the world, even though serious adverse drug reactions (ADRs) have been reported with the use of these drugs, said speakers at the American College of Clinical Pharmacy (ACCP)/European Society for Clinical Pharmacy (ESCP) International Congress on Clinical Pharmacy meeting in Orlando, Florida.

Clopidogrel plus aspirin decreases stroke risk in patients with AF who cannot take warfarin

April 21, 2009

Among patients with atrial fibrillation (AF) who are deemed unsuitable for warfarin treatment or who are unwilling to take it, clopidogrel plus aspirin is superior to aspirin alone in preventing vascular events, including strokes, said Stuart Connolly, MD, at the American College of Cardiology 58th Annual Scientific Session.

ADVERTISEMENT



Stay connected to Formulary
Receive web-exclusive articles, clinical news, and conference updates!

ADVERTISEMENT

Modern Medicine logoFormulary archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.

Keep visiting FormularyJournal.com for fresh content, news, opinions, editor's blogs and more.

ADVERTISEMENT

Click here